EdgarLookup
SC 13D/A

AMENDMENT NO. 2 TO THE SCHEDULE 13D

Company
Oruka Therapeutics, Inc.
Filed
April 14, 2022
Accession Number
0000921895-22-001251
View Document ↗ View on SEC.gov ↗